Insider Trading & Ownership - Terns Pharmaceuticals Inc. (TERN)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Terns Pharmaceuticals Inc.
Goto 0, 1, 2, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-12-05
Purchase
2024-12-09
6:04 pm
Terns Pharmaceuticals Inc.TERNBurroughs Amy L.
Chief Executive Officer
15,450$7.15$110,46819,099
(Direct)
View
2024-09-12
Purchase
2024-09-17
7:48 pm
Terns Pharmaceuticals Inc.TERNLu Hongbo
Director
476,190$10.5$4,999,995476,190
(Indirect)
View
2024-09-10
Sale
2024-09-12
6:10 pm
Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer
10,000$11$110,000146,940
(Direct)
View
2024-09-09
Sale
2024-09-11
6:00 pm
Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Director
17,235$10$172,35015,000
(Direct)
View
2024-08-01
Sale
2024-08-05
8:11 pm
Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Director
15,000$7.572$113,58015,000
(Direct)
View
2024-07-15
Sale
2024-07-17
8:53 pm
Terns Pharmaceuticals Inc.TERNGORDON CARL L
Director
10% Owner
56,164$10$561,640755,635
(Indirect)
View
2024-07-15
Sale
2024-07-17
8:48 pm
Terns Pharmaceuticals Inc.TERNORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Asia GP III L.P.
OrbiMed Advisors III Ltd
OrbiMed Genesis GP LLC
Director
10% Owner
56,164$10$561,640755,635
(Indirect)
View
2024-07-15
Sale
2024-07-17
7:56 pm
Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Director
14,765$10$147,66064,870
(Direct)
View
2024-05-31
Purchase
2024-06-04
6:06 pm
Terns Pharmaceuticals Inc.TERNYoon Seokho Bryan
COO and General Counsel
4,791$4.44$21,27291,940
(Direct)
View
2024-05-31
Purchase
2024-06-04
6:05 pm
Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer
4,791$4.44$21,27291,940
(Direct)
View
2024-04-01
Sale
2024-04-03
8:47 pm
Terns Pharmaceuticals Inc.TERNVivo Opportunity LLC
Vivo Opportunity Fund Holdings L.P.
Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
420,663$6.6487$2,796,859268,573
(Indirect)
View
2023-11-30
Purchase
2023-12-04
6:03 pm
Terns Pharmaceuticals Inc.TERNYoon Seokho Bryan
COO and General Counsel
743$3.78$2,80918,399
(Direct)
View
2023-11-30
Purchase
2023-12-04
6:03 pm
Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer
743$3.78$2,80918,399
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-12-12
Option Award
2024-12-16
6:26 pm
N/A
2034-12-11
Terns Pharmaceuticals Inc.TERNKuriakose Emil
Chief Medical Officer
120,000$0120,000
(Direct)
View
2024-11-18
Option Award
2024-11-19
6:30 pm
N/A
2034-11-17
Terns Pharmaceuticals Inc.TERNTurner Heather D
Director
64,000$064,000
(Direct)
View
2024-09-10
Exercise
2024-09-12
6:10 pm
N/A
2032-01-25
Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer
10,000$0146,940
(Direct)
View
2024-09-10
Exercise
2024-09-12
6:10 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer
10,000$5.36146,940
(Direct)
View
2024-09-09
Exercise
2024-09-11
6:00 pm
2023-06-12
2032-06-15
Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Director
17,235$015,000
(Direct)
View
2024-09-09
Exercise
2024-09-11
6:00 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Director
17,235$1.8215,000
(Direct)
View
2024-07-15
Exercise
2024-07-17
7:56 pm
2023-06-12
2032-06-15
Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Director
14,765$064,870
(Direct)
View
2024-07-15
Exercise
2024-07-17
7:56 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Director
14,765$1.8264,870
(Direct)
View
2024-07-01
Option Award
2024-07-02
6:38 pm
N/A
2034-06-30
Terns Pharmaceuticals Inc.TERNTripuraneni Radhika
Director
4,676$04,676
(Direct)
View
2024-07-01
Option Award
2024-07-02
6:37 pm
N/A
2034-06-30
Terns Pharmaceuticals Inc.TERNTaylor Ann Elizabeth
Director
4,676$04,676
(Direct)
View
2024-07-01
Option Award
2024-07-02
6:36 pm
N/A
2034-06-30
Terns Pharmaceuticals Inc.TERNLu Hongbo
Director
4,676$04,676
(Direct)
View
2024-07-01
Option Award
2024-07-02
6:36 pm
N/A
2034-06-30
Terns Pharmaceuticals Inc.TERNKINDLER JEFFREY B
Director
4,676$04,676
(Direct)
View
2024-07-01
Option Award
2024-07-02
6:36 pm
N/A
2034-06-30
Terns Pharmaceuticals Inc.TERNGORDON CARL L
Director
10% Owner
4,676$04,676
(Direct)
View
2024-07-01
Option Award
2024-07-02
6:36 pm
N/A
2034-06-30
Terns Pharmaceuticals Inc.TERNFELLOWS DAVID A
Director
8,183$08,183
(Direct)
View
2024-06-10
Option Award
2024-06-14
6:05 pm
N/A
2034-06-09
Terns Pharmaceuticals Inc.TERNTripuraneni Radhika
Director
32,000$032,000
(Direct)
View
2024-06-10
Option Award
2024-06-14
6:05 pm
N/A
2034-06-09
Terns Pharmaceuticals Inc.TERNTaylor Ann Elizabeth
Director
32,000$032,000
(Direct)
View
2024-06-10
Option Award
2024-06-14
6:04 pm
N/A
2034-06-09
Terns Pharmaceuticals Inc.TERNLu Hongbo
Director
32,000$032,000
(Direct)
View
2024-06-10
Option Award
2024-06-14
6:04 pm
N/A
2034-06-09
Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Director
32,000$032,000
(Direct)
View
2024-06-10
Option Award
2024-06-14
6:04 pm
N/A
2034-06-09
Terns Pharmaceuticals Inc.TERNGORDON CARL L
Director
10% Owner
32,000$032,000
(Direct)
View
2024-06-10
Option Award
2024-06-14
6:04 pm
N/A
2034-06-09
Terns Pharmaceuticals Inc.TERNKINDLER JEFFREY B
Director
32,000$032,000
(Direct)
View
2024-06-10
Option Award
2024-06-14
6:03 pm
N/A
2034-06-09
Terns Pharmaceuticals Inc.TERNFELLOWS DAVID A
Director
32,000$032,000
(Direct)
View
2024-05-01
Option Award
2024-05-02
5:29 pm
N/A
2034-04-30
Terns Pharmaceuticals Inc.TERNJung Melita Sun
Chief Business Officer
475,000$0475,000
(Direct)
View

Ownership
2024-03-19
7:26 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNKuriakose Emil
Chief Medical Officer
0$0456,250
(Direct)
View
2024-03-01
Option Award
2024-03-05
6:01 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNBurroughs Amy L.
Chief Executive Officer
1,400,000$01,400,000
(Direct)
View
2024-01-23
Option Award
2024-01-25
7:18 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Sr. Advisor & Strategy Officer
15,000$030,000
(Direct)
View
2024-01-23
Option Award
2024-01-25
7:18 pm
N/A
2034-01-22
Terns Pharmaceuticals Inc.TERNYoon Seokho Bryan
COO and General Counsel
206,250$0224,649
(Direct)
View
2024-01-23
Option Award
2024-01-25
7:17 pm
N/A
2034-01-22
Terns Pharmaceuticals Inc.TERNVignola Mark J.
Chief Financial Officer
206,250$0224,649
(Direct)
View
2024-01-23
Option Award
2024-01-25
7:17 pm
N/A
2034-01-22
Terns Pharmaceuticals Inc.TERNQuirk Erin
President, Head of R&D
225,000$0225,000
(Direct)
View
2023-11-15
Option Award
2023-11-17
6:10 pm
N/A
N/A
Terns Pharmaceuticals Inc.TERNQuigley Jill M.
Sr. Advisor & Strategy Officer
15,000$015,000
(Direct)
View
2023-06-12
Option Award
2023-06-14
7:02 pm
N/A
2033-06-11
Terns Pharmaceuticals Inc.TERNTaylor Ann Elizabeth
Director
32,000$032,000
(Direct)
View
Goto 0, 1, 2, Next